Investment banks are resuming leveraged buyout financing at scale after absorbing $8-12 billion in collective write-downs on M&A bridge loans extended during the 2021-2022 peak. Syndication desks at Goldman Sachs, JPMorgan, and Bank of America are pricing new tranches for private equity sponsors, marking the first sustained uptick since rates began falling in Q4 2024.

The mechanics are straightforward. Banks held acquisition debt on balance sheets when rising rates killed bond markets and loan buyers disappeared. Those positions repriced downward by 18-24% on average, triggering mark-to-market losses through 2023. Now, with the 10-year Treasury below 4.2% and high-yield spreads tightening 110 basis points from their peak, secondary loan markets are functioning again. Banks can syndicate, close deals, and avoid the capital drag that paralyzed M&A for eighteen months.

The implications extend beyond bank earnings. Private equity firms hold $2.8 trillion in dry powder globally, with deployment rates running 40% below five-year averages through 2023. If banks sustain underwriting appetite, that capital moves off sidelines. Sponsor-backed deals typically close 90-120 days after debt commitment letters, meaning transaction volume should reflect this shift by late Q2 2025. Healthcare services, industrial automation, and enterprise software are seeing early bidding activity, sectors where EBITDA multiples compressed 2-3 turns during the freeze and remain 15-20% below 2021 peaks.

Second-order effects matter here. European banks, particularly Barclays and Deutsche, carry heavier legacy exposure to UK and German mid-market LBOs than their US counterparts. Their willingness to underwrite new deals signals confidence that central banks will hold rates steady or continue cutting. If they prove wrong and rates reverse, balance sheets take another hit. The risk is asymmetric: banks earn 150-200 basis points in syndication fees but face potential 15-20% principal losses if markets seize again.

Operators and allocators should track three metrics over the next 90 days: announced deal volume in the $2-5 billion enterprise value range, where bank balance sheet capacity is tested; high-yield bond issuance from sponsor-backed issuers, which competes with bank loans for the same capital; and CLO formation, which absorbs 60-70% of leveraged loan supply and determines how much risk banks must warehouse. A slowdown in any of those three variables means the window is narrower than syndication desks are pricing.

JPMorgan disclosed $1.2 billion in bridge loan commitments in its January earnings supplement, triple the prior quarter.